Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 118 citing articles:

Treatment strategies for ADHD: an evidence-based guide to select optimal treatment
Arthur Caye, James M. Swanson, David Coghill, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 3, pp. 390-408
Closed Access | Times Cited: 240
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
Safia Sharif, Amira Guirguis, Suzanne Fergus, et al.
Brain Sciences (2021) Vol. 11, Iss. 3, pp. 355-355
Open Access | Times Cited: 116
A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes
Emmanuel J.M. Mignot
Neurotherapeutics (2012) Vol. 9, Iss. 4, pp. 739-752
Open Access | Times Cited: 204
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
Christopher L. German, Michelle Baladi, Lisa M. McFadden, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 1005-1024
Open Access | Times Cited: 164
R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse
Claus J. Løland, Maddalena Mereu, Oluyomi M. Okunola, et al.
Biological Psychiatry (2012) Vol. 72, Iss. 5, pp. 405-413
Open Access | Times Cited: 135
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter
Maarten E. A. Reith, Bruce E. Blough, Weimin Hong, et al.
Drug and Alcohol Dependence (2014) Vol. 147, pp. 1-19
Open Access | Times Cited: 125
Nonclassical Pharmacology of the Dopamine Transporter: Atypical Inhibitors, Allosteric Modulators, and Partial Substrates
Kyle C. Schmitt, Richard B. Rothman, Maarten E. A. Reith
Journal of Pharmacology and Experimental Therapeutics (2013) Vol. 346, Iss. 1, pp. 2-10
Open Access | Times Cited: 109
Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease
Kelly M. Lohr, Shababa T. Masoud, Ali Salahpour, et al.
European Journal of Neuroscience (2016) Vol. 45, Iss. 1, pp. 20-33
Open Access | Times Cited: 102
Overview of Monoamine Transporters
Shaili Aggarwal, Ole V. Mortensen
Current Protocols in Pharmacology (2017) Vol. 79, Iss. 1
Open Access | Times Cited: 94
Importance of cholesterol in dopamine transporter function
Kymry T. Jones, Juan Zhen, Maarten E. A. Reith
Journal of Neurochemistry (2012) Vol. 123, Iss. 5, pp. 700-715
Open Access | Times Cited: 95
Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets
Aaruni Saxena, Vishal M. Balaramnavar, Thomas Hohlfeld, et al.
European Journal of Pharmacology (2013) Vol. 721, Iss. 1-3, pp. 215-224
Closed Access | Times Cited: 87
Modafinil Abrogates Methamphetamine-Induced Neuroinflammation and Apoptotic Effects in the Mouse Striatum
Mariana Raineri, Betina González, Belén Goitia, et al.
PLoS ONE (2012) Vol. 7, Iss. 10, pp. e46599-e46599
Open Access | Times Cited: 77
Modafinil as a Catecholaminergic Agent: Empirical Evidence and Unanswered Questions
Jonathan P. Wisor
Frontiers in Neurology (2013) Vol. 4
Open Access | Times Cited: 73
Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors
Jianjing Cao, Rachel D. Slack, Oluyomi M. Bakare, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 23, pp. 10676-10691
Open Access | Times Cited: 63
Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport
Wei‐Lun Sun, Pamela M. Quizon, Yaxia Yuan, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 61
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
Michael J. Colwell, Hosana Tagomori, Sarah Chapman, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Overview of the structure and function of the dopamine transporter and its protein interactions
Binod Nepal, Sanjay Kumar Das, Maarten E. A. Reith, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 17
Practical Use and Risk of Modafinil, a Novel Waking Drug
Dong‐Soo Kim
Environmental Health and Toxicology (2012) Vol. 27, pp. e2012007-e2012007
Open Access | Times Cited: 69
Differentiating Physicochemical Properties between Addictive and Nonaddictive ADHD Drugs Revealed by Molecular Dynamics Simulation Studies
Panpan Wang, Xiaoyu Zhang, Tingting Fu, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1416-1428
Closed Access | Times Cited: 60
Differentiating physicochemical properties between NDRIs and sNRIs clinically important for the treatment of ADHD
Panpan Wang, Tingting Fu, Xiaoyu Zhang, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2017) Vol. 1861, Iss. 11, pp. 2766-2777
Closed Access | Times Cited: 56
Neuropsychiatric disease–associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes
Freja Herborg, Thorvald F. Andreassen, Frida Berlin, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 19, pp. 7250-7262
Open Access | Times Cited: 50
Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells
Pieter Beerepoot, Vincent Lam, Ali Salahpour
Journal of Biological Chemistry (2016) Vol. 291, Iss. 42, pp. 22053-22062
Open Access | Times Cited: 49
Vigor, Effort-Related Aspects of Motivation and Anhedonia
Michael T. Treadway, John D. Salamone
Current topics in behavioral neurosciences (2022), pp. 325-353
Closed Access | Times Cited: 27
Addiction-related gene regulation: Risks of exposure to cognitive enhancers vs. other psychostimulants
Heinz Steiner, Vincent Van Waes
Progress in Neurobiology (2012) Vol. 100, pp. 60-80
Open Access | Times Cited: 54
Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: Focus on dopamine, norepinephrine and glutamate
Colin N. Haile, James J. Mahoney, Thomas F. Newton, et al.
Pharmacology & Therapeutics (2012) Vol. 134, Iss. 2, pp. 260-277
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top